SMDT1
gene geneOn this page
Also known as dJ186O1.1DDDDEMRE
Summary
SMDT1 (single-pass membrane protein with aspartate rich tail 1, HGNC:25055) is a protein-coding gene on chromosome 22q13.2, encoding Essential MCU regulator, mitochondrial (Q9H4I9). Essential regulatory subunit of the mitochondrial calcium uniporter complex (uniplex), a complex that mediates calcium uptake into mitochondria.
This gene encodes a core regulatory component of a calcium channel in the mitochondrial inner membrane.
Source: NCBI Gene 91689 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 23 total
- MANE Select transcript:
NM_033318
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25055 |
| Approved symbol | SMDT1 |
| Name | single-pass membrane protein with aspartate rich tail 1 |
| Location | 22q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ186O1.1, DDDD, EMRE |
| Ensembl gene | ENSG00000183172 |
| Ensembl biotype | protein_coding |
| OMIM | 615588 |
| Entrez | 91689 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 13 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000331479, ENST00000422252, ENST00000484235, ENST00000874726, ENST00000874727, ENST00000874728, ENST00000874729, ENST00000874730, ENST00000874731, ENST00000874732, ENST00000924437, ENST00000924438, ENST00000924439, ENST00000924440, ENST00000951293
RefSeq mRNA: 1 — MANE Select: NM_033318
NM_033318
CCDS: CCDS14031
Canonical transcript exons
ENST00000331479 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001306958 | 42079700 | 42079954 |
| ENSE00001370607 | 42083119 | 42084284 |
| ENSE00003468043 | 42081925 | 42082065 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 98.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.6928 / max 402.0772, expressed in 1820 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 192554 | 32.8168 | 1816 |
| 192555 | 4.4162 | 1642 |
| 192556 | 1.7111 | 1168 |
| 192553 | 0.7487 | 477 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 98.51 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.03 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.87 | gold quality |
| body of stomach | UBERON:0001161 | 97.58 | gold quality |
| left ovary | UBERON:0002119 | 97.56 | gold quality |
| muscle of leg | UBERON:0001383 | 97.51 | gold quality |
| granulocyte | CL:0000094 | 97.49 | gold quality |
| monocyte | CL:0000576 | 97.47 | gold quality |
| leukocyte | CL:0000738 | 97.47 | gold quality |
| body of pancreas | UBERON:0001150 | 97.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 97.36 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.32 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.31 | gold quality |
| right atrium auricular region | UBERON:0006631 | 97.25 | gold quality |
| right ovary | UBERON:0002118 | 97.22 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 97.15 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 97.13 | gold quality |
| endocervix | UBERON:0000458 | 97.12 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 97.09 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.07 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 97.02 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 97.01 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.00 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.95 | gold quality |
| lower esophagus | UBERON:0013473 | 96.94 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 96.94 | gold quality |
| cortical plate | UBERON:0005343 | 96.93 | gold quality |
| left uterine tube | UBERON:0001303 | 96.87 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.86 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.83 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 16.71 |
| E-MTAB-8142 | yes | 14.20 |
| E-MTAB-7606 | no | 668.16 |
| E-MTAB-8911 | no | 149.23 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
50 targeting SMDT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-202-3P | 99.84 | 71.41 | 1290 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-2116-3P | 99.74 | 64.32 | 889 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-3147 | 99.52 | 66.34 | 388 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-1294 | 98.91 | 69.26 | 1030 |
| HSA-MIR-9986 | 98.91 | 69.28 | 1024 |
Literature-anchored findings (GeneRIF, showing 8)
- EMRE (C22orf32) is an integral mitochondrial inner membrane protein and component of the mitochondrial uniporter complex (uniplex). It is essential for uniporter channel activity. In its absence, the pore does not interact with its regulators MICU1/2. (PMID:24231807)
- EMRE is essential for in vivo uniporter current and additionally bridges the calcium-sensing role of MICU1 and MICU2 with the calcium-conducting role of MCU. (PMID:24231807)
- Our experiments provide novel details about how MCU/EMRE is regulated by MICU1 and an original approach to investigate MCU/EMRE activation in intact cells. (PMID:26489515)
- Here, the authors determine the transmembrane orientation of EMRE, and show that its known MCU-activating function is mediated by the interaction of transmembrane helices from both proteins. (PMID:27099988)
- SMDT1 overexpression induced mitochondrial mediated apoptosis. (PMID:30782485)
- the human MCU-EMRE complex, which constitutes the minimal channel components among metazoans, provides a framework for future mechanistic studies on MCU. (PMID:31080062)
- Mechanisms of EMRE-Dependent MCU Opening in the Mitochondrial Calcium Uniporter Complex. (PMID:33296646)
- SMDT1 variants impair EMRE-mediated mitochondrial calcium uptake in patients with muscle involvement. (PMID:37454773)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | smdt1a | ENSDARG00000095826 |
| danio_rerio | smdt1b | ENSDARG00000098852 |
| mus_musculus | Smdt1 | ENSMUSG00000022452 |
| rattus_norvegicus | ENSRNOG00000066493 | |
| drosophila_melanogaster | EMRE | FBGN0062440 |
| caenorhabditis_elegans | WBGENE00008980 |
Protein
Protein identifiers
Essential MCU regulator, mitochondrial — Q9H4I9 (reviewed: Q9H4I9)
Alternative names: Single-pass membrane protein with aspartate-rich tail 1, mitochondrial
All UniProt accessions (2): Q9H4I9, F8WDX6
UniProt curated annotations — full annotation on UniProt →
Function. Essential regulatory subunit of the mitochondrial calcium uniporter complex (uniplex), a complex that mediates calcium uptake into mitochondria. Required to bridge the calcium-sensing proteins MICU1 with the calcium-conducting subunit MCU. Acts by mediating activation of MCU and retention of MICU1 to the MCU pore, in order to ensure tight regulation of the uniplex complex and appropriate responses to intracellular calcium signaling.
Subunit / interactions. Component of the uniplex complex, composed of MCU, EMRE/SMDT1, MICU1 and MICU2 (or MICU3) in a 4:4:1:1 stoichiometry. The number of EMRE/SMDT1 molecules is hovewer variable, ranging from 1 to 4 copies per uniplex complex, leading to uniplex complexes with distinct gatekeeping profiles. Interacts (via its C-terminal poly-Asp tail) with MCUR1; the interaction is direct. Unprocessed form interacts (via transit peptide) with MAIP1.
Subcellular location. Mitochondrion inner membrane.
Post-translational modifications. Undergoes proteolytic degradation in neurons: degraded by AFG3L2 and SPG7 before SMDT1/EMRE assembly with the uniporter complex, limiting the availability of SMDT1/EMRE for MCU assembly and promoting efficient assembly of gatekeeper subunits with MCU.
Domain organisation. The GXXXX[G/A/S] motif at the C-terminal part of the transmembrane region mediates interaction with MCU and is required to activate the calcium-conducting pore in the uniporter complex. The poly-Asp region at the C-terminus mediates interaction with the polybasic region of MICU1.
Similarity. Belongs to the SMDT1/EMRE family.
RefSeq proteins (1): NP_201575* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018782 | MCU_reg | Family |
Pfam: PF10161
UniProt features (21 total): mutagenesis site 8, helix 3, topological domain 2, transit peptide 1, chain 1, strand 1, turn 1, transmembrane region 1, region of interest 1, short sequence motif 1, sequence variant 1
Structure
Experimental structures (PDB)
8 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6WDN | ELECTRON MICROSCOPY | 3.2 |
| 6K7X | ELECTRON MICROSCOPY | 3.27 |
| 6K7Y | ELECTRON MICROSCOPY | 3.6 |
| 6O5B | ELECTRON MICROSCOPY | 3.6 |
| 6WDO | ELECTRON MICROSCOPY | 3.6 |
| 6O58 | ELECTRON MICROSCOPY | 3.8 |
| 6XJV | ELECTRON MICROSCOPY | 4.17 |
| 6XJX | ELECTRON MICROSCOPY | 4.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H4I9-F1 | 73.00 | 0.20 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (8):
| Position | Phenotype |
|---|---|
| 60 | abolished interaction with mcu. |
| 67–70 | does not affect interaction with mcu. |
| 81 | abolishes calcium uptake into mitochondria. |
| 83 | promotes association with mcu, protecting smdt1/emre from degradation by afg3l2 and sp7. |
| 85 | abolishes calcium uptake into mitochondria. promotes association with mcu, protecting smdt1/emre from degradation by afg |
| 101–107 | abolishes regulation of calcium uptake into mitochondria. |
| 58 | abolished interaction with mcu. |
| 59 | abolished interaction with mcu. |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-8949215 | Mitochondrial calcium ion transport |
| R-HSA-8949664 | Processing of SMDT1 |
| R-HSA-9837999 | Mitochondrial protein degradation |
MSigDB gene sets: 147 (showing top):
CREBP1_Q2, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, TGIF_01, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_CELLULAR_RESPONSE_TO_STARVATION, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, CAGCCTC_MIR4855P, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_RESPONSE_TO_STARVATION, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, GOBP_HOMEOSTATIC_PROCESS
GO Biological Process (7): mitochondrial calcium ion transmembrane transport (GO:0006851), calcium import into the mitochondrion (GO:0036444), mitochondrial calcium ion homeostasis (GO:0051560), cellular response to calcium ion starvation (GO:0072732), monoatomic ion transport (GO:0006811), calcium ion transport (GO:0006816), cellular response to calcium ion (GO:0071277)
GO Molecular Function (3): protein-macromolecule adaptor activity (GO:0030674), channel activator activity (GO:0099103), protein binding (GO:0005515)
GO Cellular Component (6): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial matrix (GO:0005759), uniplex complex (GO:1990246), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Transport of small molecules | 1 |
| Mitochondrial calcium ion transport | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 2 |
| cellular anatomical structure | 2 |
| calcium ion transmembrane transport | 1 |
| mitochondrial calcium ion transmembrane transport | 1 |
| intercellular transport | 1 |
| intracellular calcium ion homeostasis | 1 |
| cellular response to starvation | 1 |
| transport | 1 |
| metal ion transport | 1 |
| response to calcium ion | 1 |
| cellular response to metal ion | 1 |
| protein binding | 1 |
| molecular adaptor activity | 1 |
| channel activity | 1 |
| channel regulator activity | 1 |
| transporter activator activity | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| intracellular organelle lumen | 1 |
| calcium channel complex | 1 |
| inner mitochondrial membrane protein complex | 1 |
Protein interactions and networks
STRING
826 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMDT1 | MICU2 | Q8IYU8 | 999 |
| SMDT1 | MICU1 | Q9BPX6 | 999 |
| SMDT1 | MCUB | Q9NWR8 | 997 |
| SMDT1 | MCUR1 | Q96AQ8 | 995 |
| SMDT1 | MICU3 | Q86XE3 | 993 |
| SMDT1 | MCU | Q8NE86 | 988 |
| SMDT1 | SLC8B1 | Q6J4K2 | 661 |
| SMDT1 | LETM1 | O95202 | 650 |
| SMDT1 | VDAC1 | P21796 | 615 |
| SMDT1 | SLC25A23 | Q9BV35 | 594 |
| SMDT1 | FADD | Q13158 | 589 |
| SMDT1 | TRADD | Q15628 | 576 |
| SMDT1 | AFG3L2 | Q9Y4W6 | 574 |
| SMDT1 | MAIP1 | Q8WWC4 | 572 |
| SMDT1 | HSPA9 | P30036 | 560 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MCU | SMDT1 | psi-mi:“MI:0915”(physical association) | 0.760 |
| ASPH | STXBP3 | psi-mi:“MI:0914”(association) | 0.640 |
| SMDT1 | MYLK2 | psi-mi:“MI:0915”(physical association) | 0.590 |
| GPR183 | NRP1 | psi-mi:“MI:0914”(association) | 0.530 |
| MCU | MICU2 | psi-mi:“MI:0914”(association) | 0.530 |
| SMDT1 | MICU2 | psi-mi:“MI:0915”(physical association) | 0.490 |
| PDCD1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| EID3 | ACSL4 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A4 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| IL2RA | LTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| ASPH | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| SMDT1 | COL1A1 | psi-mi:“MI:0914”(association) | 0.350 |
| SMDT1 | MTOR | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | EIF2B2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | EIF2B5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | EIF2B1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | MCU | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | EIF2B3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | EIF2B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMDT1 | BZW2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (35): SMDT1 (Affinity Capture-RNA), SMDT1 (Affinity Capture-MS), SMDT1 (Affinity Capture-MS), MYLK2 (Affinity Capture-MS), SMDT1 (Affinity Capture-MS), SMDT1 (Affinity Capture-MS), SMDT1 (Affinity Capture-MS), SMDT1 (Affinity Capture-MS), MYLK2 (Affinity Capture-MS), EIF2B1 (Affinity Capture-MS), EIF2B2 (Affinity Capture-MS), EIF2B4 (Affinity Capture-MS), BZW2 (Affinity Capture-MS), MCU (Affinity Capture-MS), EIF2B5 (Affinity Capture-MS)
ESM2 similar proteins: A0JPH4, A2A8U2, A3KN05, A6H773, A6QPI4, O14524, Q05B67, Q08BI9, Q15070, Q1G3L1, Q2M2S2, Q2NL34, Q3SYV3, Q3SZV6, Q4KLZ1, Q5EA03, Q5G2C6, Q5GH64, Q5RC29, Q5RE99, Q5SNT2, Q5SPH9, Q5T6X4, Q5XIJ4, Q5ZLJ4, Q5ZML6, Q6AY04, Q6DVA0, Q6PCT8, Q800L1, Q86XE3, Q8BGA9, Q8BGY7, Q8IYL2, Q8NC56, Q8WWC4, Q921N7, Q95123, Q96B77, Q96ND0
Diamond homologs: D6X268, Q17ED3, Q28ED6, Q290M9, Q2M2S2, Q5XG64, Q7JX57, Q7QHP6, Q9DB10, Q9H4I9, Q9U3I4
SIGNOR signaling
4 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SMDT1 | “form complex” | MCU_MICUB_variant | binding |
| SMDT1 | “form complex” | MCU_MICU1_variant | binding |
| SMDT1 | “form complex” | MCU_MICU3_variant | binding |
| SMDT1 | “form complex” | MCU_MICU2_variant | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 24 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| oligodendrocyte development | 5 | 130.8× | 3e-08 |
| response to heat | 6 | 109.9× | 2e-09 |
| response to peptide hormone | 5 | 85.2× | 2e-07 |
| translational initiation | 5 | 78.0× | 3e-07 |
| response to glucose | 5 | 55.5× | 1e-06 |
| T cell receptor signaling pathway | 5 | 33.0× | 2e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
676 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:42079955:G:GG | donor_gain | 1.0000 |
| 22:42082062:ACAGG:A | donor_loss | 1.0000 |
| 22:42082065:GGTAA:G | donor_loss | 1.0000 |
| 22:42082067:T:A | donor_loss | 1.0000 |
| 22:42087055:GTTA:G | donor_loss | 1.0000 |
| 22:42087056:TTACC:T | donor_loss | 1.0000 |
| 22:42087057:TACCT:T | donor_loss | 1.0000 |
| 22:42087058:ACCTT:A | donor_loss | 1.0000 |
| 22:42087059:C:CA | donor_loss | 1.0000 |
| 22:42087080:C:CT | donor_gain | 1.0000 |
| 22:42087081:C:CT | donor_gain | 1.0000 |
| 22:42087171:GTGCA:G | acceptor_gain | 1.0000 |
| 22:42087172:TGCA:T | acceptor_gain | 1.0000 |
| 22:42087173:GCA:G | acceptor_gain | 1.0000 |
| 22:42087174:CA:C | acceptor_gain | 1.0000 |
| 22:42087174:CAC:C | acceptor_gain | 1.0000 |
| 22:42087176:C:CC | acceptor_gain | 1.0000 |
| 22:42079951:GAAA:G | donor_gain | 0.9900 |
| 22:42080398:A:AG | acceptor_gain | 0.9900 |
| 22:42080399:G:GG | acceptor_gain | 0.9900 |
| 22:42081919:CTGCA:C | acceptor_loss | 0.9900 |
| 22:42081920:TGCA:T | acceptor_loss | 0.9900 |
| 22:42081921:GCA:G | acceptor_loss | 0.9900 |
| 22:42081922:CA:C | acceptor_loss | 0.9900 |
| 22:42081923:A:AG | acceptor_gain | 0.9900 |
| 22:42081923:AG:A | acceptor_loss | 0.9900 |
| 22:42081924:G:GC | acceptor_loss | 0.9900 |
| 22:42081924:G:GG | acceptor_gain | 0.9900 |
| 22:42081924:GAT:G | acceptor_gain | 0.9900 |
| 22:42082066:G:GG | donor_gain | 0.9900 |
AlphaMissense
690 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:42082030:T:C | F98L | 0.999 |
| 22:42082032:T:A | F98L | 0.999 |
| 22:42082032:T:G | F98L | 0.999 |
| 22:42082004:C:A | A89D | 0.998 |
| 22:42082013:T:A | L92H | 0.998 |
| 22:42082031:T:G | F98C | 0.998 |
| 22:42081991:A:C | S85R | 0.997 |
| 22:42081993:C:A | S85R | 0.997 |
| 22:42081993:C:G | S85R | 0.997 |
| 22:42082017:G:C | E93D | 0.996 |
| 22:42082017:G:T | E93D | 0.996 |
| 22:42081992:G:A | S85N | 0.995 |
| 22:42082028:T:C | I97T | 0.995 |
| 22:42081979:G:A | G81R | 0.994 |
| 22:42081979:G:C | G81R | 0.994 |
| 22:42081980:G:A | G81E | 0.994 |
| 22:42081996:G:C | K86N | 0.993 |
| 22:42081996:G:T | K86N | 0.993 |
| 22:42082013:T:C | L92P | 0.993 |
| 22:42082028:T:G | I97S | 0.993 |
| 22:42081992:G:T | S85I | 0.992 |
| 22:42082028:T:A | I97N | 0.992 |
| 22:42082031:T:C | F98S | 0.992 |
| 22:42081989:T:A | I84N | 0.991 |
| 22:42082022:A:C | H95P | 0.991 |
| 22:42082006:G:C | A90P | 0.990 |
| 22:42082010:T:C | L91P | 0.990 |
| 22:42082030:T:A | F98I | 0.990 |
| 22:42081971:T:C | L78P | 0.989 |
| 22:42082016:A:T | E93V | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000656075 (22:42078630 G>A), RS1001170432 (22:42083202 G>A), RS1002144996 (22:42081976 G>C), RS1002177775 (22:42081761 C>A,T), RS1002624546 (22:42081215 G>A), RS1002809585 (22:42084658 G>C,T), RS1002987560 (22:42078474 G>A), RS1003805175 (22:42078768 T>A,C), RS1004158160 (22:42079400 G>C), RS1004221577 (22:42081740 G>A), RS1004594510 (22:42081479 T>C), RS1005178425 (22:42080460 G>C), RS1006179803 (22:42079365 T>C), RS1006757747 (22:42084762 C>A), RS1007331361 (22:42083751 T>C)
Disease associations
OMIM: gene MIM:615588 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002539_95 | Schizophrenia | 2.000000e-09 |
| GCST004521_160 | Autism spectrum disorder or schizophrenia | 3.000000e-08 |
| GCST004521_244 | Autism spectrum disorder or schizophrenia | 4.000000e-09 |
| GCST006803_13 | Schizophrenia | 2.000000e-14 |
| GCST010002_83 | Refractive error | 2.000000e-27 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs1807493 | PHETA2, SMDT1 | 0.00 | 0 |
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 5 |
| Tunicamycin | increases expression | 2 |
| arsenite | affects binding, increases reaction | 1 |
| methylparaben | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Gold Compounds | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D8AX | Ubigene A-549 SMDT1 KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.